Myrica kandtiana
Myrica kandtiana · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Myrica kandtiana is a significant botanical species known for its potential therapeutic applications in traditional medicine. Recent scientific investigations have focused on its bioactive properties, particularly regarding its antimalarial activities. Researchers are exploring how the plant's unique chemical constituents can be leveraged to combat the malaria parasite. As global health challenges persist, understanding the medicinal value of this species becomes increasingly vital. This study aims to evaluate the efficacy of Myrica kandtiana in treating conditions associated with malaria.
- Synonyms
- Morella Kandtiana
- Common names
- Not available
- Family
- Myricaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Myrica kandtiana is a botanical species that is frequently identified in scientific literature under its synonym, Morella kandtiana. While these two names may appear different, they both refer to the exact same plant within the taxonomic hierarchy. Understanding these nomenclatural connections is essential for researchers seeking to track the species across various historical records. This overlap ensures that botanical databases remain accurate and consistent regardless of which name is currently in use. Ultimately, recognizing the relationship between these terms prevents confusion when studying the plant's unique characteristics.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Myrica kandtiana is a distinctive botanical species that belongs to the kingdom Plantae. Within this vast kingdom, it is categorized under the class Equisetopsida. It specifically falls into the order Fagales, showcasing its evolutionary connections to other woody plants. Furthermore, this species is a member of the Myricaceae family, a group known for its unique characteristics. Ultimately, it is classified under the genus Myrica, defining its specific biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fagales |
| Family | Myricaceae |
| Genus | Myrica |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Myrica kandtiana is a plant species with a notable presence across several regions of the African continent. Its distribution spans much of East Tropical Africa, including the countries of Kenya, Tanzania, and Uganda. Furthermore, the species extends into West-Central Tropical Africa, establishing itself within the borders of Burundi. It can also be found thriving throughout the vast landscapes of the Democratic Republic of the Congo. This widespread range highlights the adaptability of the species across diverse African ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Myrica kandtiana is characterized by its distinct growth form as a shrub.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Myrica kandtiana stands out as one of the notable medicinal plants investigated for its potential in combating malaria. Researchers examined this species as part of a broader study involving sixteen plants frequently utilized by traditional healers in Uganda's Greater Mpigi region. By employing a heme biocrystallization inhibition library screen, the study sought to identify promising candidates for antimalarial treatment. The investigation specifically focused on the plant's ability to inhibit the formation of hemozoin, a key factor in the malaria parasite's survival. Ultimately, these pharmacological assessments provide essential early-stage evidence regarding the therapeutic utility of such traditional botanical resources.
Compounds
Conditions
Myrica kandtiana, also referred to as Morella kandtiana in the research, demonstrates significant therapeutic potential through its diverse pharmacological activities. The plant acts as a potent inhibitor in the COX-2/PGH2 pathway, which allows it to effectively treat inflammation and related disorders. Beyond its anti-inflammatory properties, this species is recognized for its medicinal use in addressing malaria. Studies investigating plants used by traditional healers in the Greater Mpigi region of Uganda highlight its role in treating malaria and fever. Consequently, the plant serves as a vital resource for managing both inflammatory conditions and antiprotozoal needs.